Cargando…
469. Temporal, Spatial, and Demographic Relationships of SARS-COV-2 Gene Target Cycle Thresholds
BACKGROUND: The optimum duration of isolation precautions (IP) for SARS-COV-2-infected individuals is uncertain. Most healthcare facilities must rely on surrogates of infectivity such as illness duration or nucleic acid amplification (NA). The availability of NA remains limited in many locations, re...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776853/ http://dx.doi.org/10.1093/ofid/ofaa439.662 |
_version_ | 1783630778271268864 |
---|---|
author | Reno, Lisa Newhart, Donna Clifford, Robert Bress, Jonathan Yu, Stephanie Hanna, John J Walsh, Edward E Lesho, Emil P |
author_facet | Reno, Lisa Newhart, Donna Clifford, Robert Bress, Jonathan Yu, Stephanie Hanna, John J Walsh, Edward E Lesho, Emil P |
author_sort | Reno, Lisa |
collection | PubMed |
description | BACKGROUND: The optimum duration of isolation precautions (IP) for SARS-COV-2-infected individuals is uncertain. Most healthcare facilities must rely on surrogates of infectivity such as illness duration or nucleic acid amplification (NA). The availability of NA remains limited in many locations, requiring laboratories to alternate platforms to provide uninterrupted support. Regulatory-driven repeat testing further stresses scarce resources. A target gene cycle threshold (Ct) of 24 has been shown to correlate with culture negativity. We sought to evaluate temporal, spatial, and demographic relationships of SARS-COV-2 Ct that could inform local infection control efforts and testing policy. METHODS: From 03-14-20 to 06-01-20, nasopharyngeal swabs from inpatients were prospectively tested weekly on an emergency-use authorized laboratory developed assay, or 1 of 3 commercial platforms targeting the RNA-dependent RNA polymerase, N, ORF1ab, S, and/or PanSARS-E genes. A regional COVID-19 registry was also queried. RESULTS: 70 inpatients were prospectively evaluated (Table). Mean time to negative was 28.5 days from symptom onset (SO) and 24.1 days from initial test. Initial Ct values were significantly lower compared to those on week 3 (Figure 1). 3.3%, 8.9%, 31.3% and 50.0% tested negative at weeks 1,2,3, and 4 respectively. Trajectories did not differ by race, gender or comorbidity. 13% had isolation precautions (IP) discontinued during admission (mean time to discontinuation 15.8 days; range 12–40). None were linked to new transmissions. 20% reverted to positive after being negative. 0% of a growing number of patients across our health system (27 at time of submission), who have had IP discontinued, were linked to new infections. Data from 180 consecutive patients were available for retrospective evaluation. Mean Ct did not differ between treated-and-released (23.0) and admitted patients (22.6), nor between ward (23.1) and intensive care unit patients (20.2) (all p > 0.4). Table [Image: see text] Figure 1 [Image: see text] CONCLUSION: Linear regression revealed that a Ct of 24 and negative Ct value will occur 8.8 and 36 days after SO (Figure 2). These findings are consistent with smaller cohorts, and they add to the growing body of evidence that test-driven approaches for maintenance of IP or patient disposition should be reconsidered. Figure 2 [Image: see text] DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-7776853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77768532021-01-07 469. Temporal, Spatial, and Demographic Relationships of SARS-COV-2 Gene Target Cycle Thresholds Reno, Lisa Newhart, Donna Clifford, Robert Bress, Jonathan Yu, Stephanie Hanna, John J Walsh, Edward E Lesho, Emil P Open Forum Infect Dis Poster Abstracts BACKGROUND: The optimum duration of isolation precautions (IP) for SARS-COV-2-infected individuals is uncertain. Most healthcare facilities must rely on surrogates of infectivity such as illness duration or nucleic acid amplification (NA). The availability of NA remains limited in many locations, requiring laboratories to alternate platforms to provide uninterrupted support. Regulatory-driven repeat testing further stresses scarce resources. A target gene cycle threshold (Ct) of 24 has been shown to correlate with culture negativity. We sought to evaluate temporal, spatial, and demographic relationships of SARS-COV-2 Ct that could inform local infection control efforts and testing policy. METHODS: From 03-14-20 to 06-01-20, nasopharyngeal swabs from inpatients were prospectively tested weekly on an emergency-use authorized laboratory developed assay, or 1 of 3 commercial platforms targeting the RNA-dependent RNA polymerase, N, ORF1ab, S, and/or PanSARS-E genes. A regional COVID-19 registry was also queried. RESULTS: 70 inpatients were prospectively evaluated (Table). Mean time to negative was 28.5 days from symptom onset (SO) and 24.1 days from initial test. Initial Ct values were significantly lower compared to those on week 3 (Figure 1). 3.3%, 8.9%, 31.3% and 50.0% tested negative at weeks 1,2,3, and 4 respectively. Trajectories did not differ by race, gender or comorbidity. 13% had isolation precautions (IP) discontinued during admission (mean time to discontinuation 15.8 days; range 12–40). None were linked to new transmissions. 20% reverted to positive after being negative. 0% of a growing number of patients across our health system (27 at time of submission), who have had IP discontinued, were linked to new infections. Data from 180 consecutive patients were available for retrospective evaluation. Mean Ct did not differ between treated-and-released (23.0) and admitted patients (22.6), nor between ward (23.1) and intensive care unit patients (20.2) (all p > 0.4). Table [Image: see text] Figure 1 [Image: see text] CONCLUSION: Linear regression revealed that a Ct of 24 and negative Ct value will occur 8.8 and 36 days after SO (Figure 2). These findings are consistent with smaller cohorts, and they add to the growing body of evidence that test-driven approaches for maintenance of IP or patient disposition should be reconsidered. Figure 2 [Image: see text] DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776853/ http://dx.doi.org/10.1093/ofid/ofaa439.662 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Reno, Lisa Newhart, Donna Clifford, Robert Bress, Jonathan Yu, Stephanie Hanna, John J Walsh, Edward E Lesho, Emil P 469. Temporal, Spatial, and Demographic Relationships of SARS-COV-2 Gene Target Cycle Thresholds |
title | 469. Temporal, Spatial, and Demographic Relationships of SARS-COV-2 Gene Target Cycle Thresholds |
title_full | 469. Temporal, Spatial, and Demographic Relationships of SARS-COV-2 Gene Target Cycle Thresholds |
title_fullStr | 469. Temporal, Spatial, and Demographic Relationships of SARS-COV-2 Gene Target Cycle Thresholds |
title_full_unstemmed | 469. Temporal, Spatial, and Demographic Relationships of SARS-COV-2 Gene Target Cycle Thresholds |
title_short | 469. Temporal, Spatial, and Demographic Relationships of SARS-COV-2 Gene Target Cycle Thresholds |
title_sort | 469. temporal, spatial, and demographic relationships of sars-cov-2 gene target cycle thresholds |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776853/ http://dx.doi.org/10.1093/ofid/ofaa439.662 |
work_keys_str_mv | AT renolisa 469temporalspatialanddemographicrelationshipsofsarscov2genetargetcyclethresholds AT newhartdonna 469temporalspatialanddemographicrelationshipsofsarscov2genetargetcyclethresholds AT cliffordrobert 469temporalspatialanddemographicrelationshipsofsarscov2genetargetcyclethresholds AT bressjonathan 469temporalspatialanddemographicrelationshipsofsarscov2genetargetcyclethresholds AT yustephanie 469temporalspatialanddemographicrelationshipsofsarscov2genetargetcyclethresholds AT hannajohnj 469temporalspatialanddemographicrelationshipsofsarscov2genetargetcyclethresholds AT walshedwarde 469temporalspatialanddemographicrelationshipsofsarscov2genetargetcyclethresholds AT leshoemilp 469temporalspatialanddemographicrelationshipsofsarscov2genetargetcyclethresholds |